Abbott Laboratories (BSP:ABTT34) Common Stock: R$132,581 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:ABTT34 Abbott Laboratories BSP:ABTT34
70 GF Score
Price R$37.61
GF Value R$55.15
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Abbott Laboratories Common Stock?

Abbott Laboratories BSP:ABTT34 -4.25% 70 Common Stock is R$132,581 Mil as of Mar. 2026. GuruFocus rates BSP:ABTT34 with a GF Score™ of 70/100 and a GF Value™ of R$55.15 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Abbott Laboratories's quarterly common stock increased from Sep. 2025 (R$136,285 Mil) to Dec. 2025 (R$139,268 Mil) but then declined from Dec. 2025 (R$139,268 Mil) to Mar. 2026 (R$132,581 Mil).

Abbott Laboratories's annual common stock increased from Dec. 2023 (R$121,853 Mil) to Dec. 2024 (R$153,458 Mil) but then declined from Dec. 2024 (R$153,458 Mil) to Dec. 2025 (R$139,268 Mil).

Abbott Laboratories Common Stock Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Common Stock Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138,375.40 129,608.59 121,853.13 153,458.45 139,267.65

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144,672.26 140,220.01 136,284.56 139,267.65 132,580.82
BSP:ABTT34
70GF Score
Abbott Laboratories BSP:ABTT34
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of R$132,581 Mil mean?
Abbott Laboratories (BSP:ABTT34) has a Common Stock of R$132,581 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Common Stock too high?
Abbott Laboratories' current Common Stock is R$132,581 Mil. Overall, Abbott Laboratories has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Common Stock compare to SYK and MDT?
Abbott Laboratories' Common Stock of R$132,581 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Common Stock is R$132,581 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (BSP:ABTT34) is currently considered Significantly Undervalued. The stock's GF Value™ is R$55.15, compared to a current price of R$37.61 — trading 31.8% below its estimated fair value. The current Common Stock is R$132,581 Mil. Abbott Laboratories' overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Abbott Laboratories (BSP:ABTT34), the current Common Stock is R$132,581 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (BSP:ABTT34) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of R$37.61 is trading 31.8% below its estimated GF Value™ of R$55.15. GuruFocus considers Abbott Laboratories to be Significantly Undervalued.

Key valuation signals for BSP:ABTT34:

  • Common Stock: R$132,581 Mil
  • GF Value™: R$55.15 vs. price of R$37.61 (31.8% below fair value)
  • GF Score™: 70/100 with 1 warning sign

No single metric tells the full story. See the BSP:ABTT34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
70GF Score

Get the complete analysis for BSP:ABTT34

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$37.61
Price
R$55.15
GF Value